Alpha-mannosidosis
Alpha-mannosidosis Serum Oligosaccharide Analysis
Alpha-mannosidosis Serum Oligosaccharide Analysis
Patients with alpha-mannosidosis cannot break down oligosaccharides containing a terminal mannose residue, leading to their accumulation in body tissues. This assay measures the GlcNAc(Man)2 oligosaccharide that accumulates in these patients and can be used for both diagnosis and treatment monitoring.
Clinical Information
Alpha-mannosidosis is caused by a deficiency of the lysosomal enzyme alpha-mannosidase, which is required for the degradation of oligosaccharides containing a terminal mannose residue. The clinical presentation of alpha-mannosidosis varies in severity, but typical features include coarse facial features, intellectual disability, skeletal abnormalities, hearing loss, hepatosplenomegaly and recurrent infections.
Technical Information
Oligosaccharides are measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Specimen Requirements
Transport Instructions
Connect With Our Experts
Call 1-800-473-9411 to speak with our team of laboratory genetic counselors for questions or additional information.
Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC
